These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25450029)

  • 21. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
    Schmitz-Dräger BJ
    Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networks.
    Buchner A; Kendlbacher M; Nuhn P; Tüllmann C; Haseke N; Stief CG; Staehler M
    Clin Genitourin Cancer; 2012 Mar; 10(1):37-42. PubMed ID: 22056212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New therapeutic opportunities in metastatic renal cell carcinoma].
    Buess M
    Praxis (Bern 1994); 2009 Apr; 98(9):481-6. PubMed ID: 19404907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium.
    Fay AP; Xie WL; Lee JL; Harshman LC; Bjarnason GA; Knox JJ; Ernst S; Wood L; Vaishamayan UN; Yuasa T; Tan MH; Rha SY; Donskov F; Agarwal N; Kollmannsberger CK; North SA; Rini BI; Choueiri TK; Heng DY
    Clin Genitourin Cancer; 2015 Apr; 13(2):150-5. PubMed ID: 25458371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perifosine in renal cell carcinoma.
    Srivastava N; Cho DC
    Expert Opin Investig Drugs; 2013 Feb; 22(2):285-91. PubMed ID: 23253151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment selection in metastatic renal cell carcinoma: more confusion or a path forward?
    Hirsch BR; George DJ; Harrison MR
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):163-71. PubMed ID: 24927264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.
    Tafreshi A; Thientosapol E; Liew MS; Guo Y; Quaggiotto M; Boyer M; Davis ID
    Asia Pac J Clin Oncol; 2014 Mar; 10(1):60-5. PubMed ID: 24152417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
    Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
    AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing Biopsy Utilization for Renal Cell Carcinoma Is Closely Associated With Treatment.
    Maurice MJ; Zhu H; Kiechle JE; Kim SP; Abouassaly R
    Urology; 2015 Nov; 86(5):906-13. PubMed ID: 26342316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic therapy for sarcomatoid renal cell carcinoma.
    Pagliaro LC; Tannir N; Sircar K; Jonasch E
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):913-20. PubMed ID: 21707288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of metastatic renal cell carcinoma.
    Reeves DJ; Liu CY
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy for non-clear-cell renal cell carcinoma.
    David KA; Milowsky MI; Nanus DM
    Clin Genitourin Cancer; 2006 Mar; 4(4):263-8. PubMed ID: 16729909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney cancer in the elderly.
    Kirkali Z
    Urol Oncol; 2009; 27(6):673-6. PubMed ID: 19879478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
    Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB
    Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma.
    Tan MH; Kanesvaran R; Li H; Tan HL; Tan PH; Wong CF; Chia KS; Teh BT; Yuen J; Chong TW
    Urology; 2010 Jun; 75(6):1365-1370; 1370.e1-3. PubMed ID: 20022084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
    J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating innovative therapeutic strategies into the management of renal cell carcinoma.
    Dutcher JP; Mourad WF; Ennis RD
    Oncology (Williston Park); 2012 Jun; 26(6):526-30, 532, 534. PubMed ID: 22870536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.